Inhibidores
Los inhibidores son moléculas que se unen a enzimas, receptores u otras proteínas para reducir o bloquear su actividad biológica. Estos compuestos se utilizan ampliamente en la investigación para estudiar vías biológicas, comprender los mecanismos de las enfermedades y desarrollar fármacos terapéuticos. Los inhibidores desempeñan un papel crucial en el tratamiento de diversas enfermedades, incluyendo el cáncer, las enfermedades cardiovasculares y las infecciones. En CymitQuimica, ofrecemos una amplia gama de inhibidores de alta calidad para apoyar su investigación en bioquímica, biología celular y desarrollo farmacéutico.
Subcategorías de "Inhibidores"
- Angiogénesis(2.797 productos)
- Apoptosis(6.275 productos)
- Ciclo celular / Checkpoint(4.805 productos)
- Cromatina / Epigenética(2.462 productos)
- Señalización citoesquelética(1.534 productos)
- Daño al ADN / Reparación del ADN(2.959 productos)
- Endocrinología / Hormonas(3.708 productos)
- Enzima(3.670 productos)
- GPCR / proteína G(9.020 productos)
- Inmunología e inflamación(3.884 productos)
- Virus de la gripe(301 productos)
- Señalización JAK / STAT(414 productos)
- Señalización MAPK(1.249 productos)
- Transportador de membrana / canal de iones(3.050 productos)
- Metabolismo(10.206 productos)
- Microbiología / Virología(7.612 productos)
- Neurociencia(10.379 productos)
- Otros inhibidores(36.012 productos)
- Reducción de oxidación(42 productos)
- Señalización PI3K / Akt / mTOR(1.442 productos)
- Proteasas / Proteasoma(1.724 productos)
- Células madre y Derivados(819 productos)
- Tirosina quinasa / adaptadores(2.035 productos)
- Ubiquitinación(1.718 productos)
Mostrar 16 subcategorías más
Se han encontrado 66683 productos de "Inhibidores"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
9(R)-HETE
CAS:9(R)-HETE, 50% of racemic mix, activates RXRγ 1.5x at 300 nM; identified by HPLC comparison.Fórmula:C20H32O3Forma y color:SolidPeso molecular:320.47AZD-4121
CAS:<p>AZD-4121 is an oral cholesterol absorption inhibitor targeting NPC1L1 for the treatment of dyslipidaemia.</p>Fórmula:C36H39F2N3O7SForma y color:SolidPeso molecular:695.77BMS-986143
CAS:BMS-986143: oral BTK inhibitor, IC50=0.26 nM, potential for autoimmune research, also targets TEC, BLK, BMX, TXK, YES1, ITK.Fórmula:C31H24Cl2N4O4Forma y color:SolidPeso molecular:587.45DRX-065
CAS:DRX-065, a deuterated R-enantiomer of pioglitazone, treats NASH without PPARγ weight gain issues.Fórmula:C19H20N2O3SPeso molecular:357.45p38 MAPK-IN-3
Compound 2c is a potent p38α MAPK inhibitor with antitumor effects, enhancing apoptosis and ROS.Fórmula:C22H17BrO2Forma y color:SolidPeso molecular:393.27SHR902275
CAS:SHR902275: potent RAF inhibitor, hits RAS mutations, oral use. cRAF IC50=1.6 nM, bRAFwt IC50=10 nM, bRAFV600E IC50=5.7 nM, hinders cell growth.Fórmula:C26H23F3N4O4Forma y color:SolidPeso molecular:512.48SSTR4 agonist 4
CAS:SSTR4 agonist 4, potent in pain research, shows promise in rodent pain models, with potential for Alzheimer's due to hippocampus activity.Fórmula:C19H26N4OForma y color:SolidPeso molecular:326.44Antibacterial agent 90
Antibacterial agent 90 (6n), a pleuromutilin derivative, targets Gram-positive pathogens and Mycoplasma pneumoniae.Fórmula:C30H42N2O6Forma y color:SolidPeso molecular:526.66PD-1/PD-L1-IN-30
CAS:PD-1/PD-L1-IN-30: Cancer research inhibitor with 0.018 μM IC50.Fórmula:C29H28F3NO5Forma y color:SolidPeso molecular:527.53VEGFR-2-IN-10
VEGFR-2-IN-10 has enhanced antiangiogenic potency against VEGFR2 phosphorylation induced by VEGF with an IC50 value of 0.7 μM and no cytotoxic effects.Fórmula:C20H21N3O2Forma y color:SolidPeso molecular:335.4PF-06462894
CAS:PF-06462894: morpholinopyrimidone, mGlu5 antagonist (Ki=6nM), no immune activation in mouse model.Fórmula:C18H23N3O3Pureza:98%Forma y color:SolidPeso molecular:329.39GSK065
CAS:GSK065 is a potent inhibitor of kynurenine-3-monooxygenase (KMO).Fórmula:C17H15ClN2O4Forma y color:SolidPeso molecular:346.77SphK2-IN-2
SphK2-IN-2 (21g) is a potent and selective inhibitor of SphK2 (IC50: 0.23 μM).Fórmula:C21H25ClN10OForma y color:SolidPeso molecular:468.94Cicaprost
CAS:Cicaprost (ZK 96480) is an IP agonist with artery relaxing effects; EC50 is 5.8 nM.Fórmula:C22H30O5Forma y color:SolidPeso molecular:374.47PNU-140457
CAS:PNU-140457 is a bio-active chemical.Fórmula:C14H14FN5O3Forma y color:SolidPeso molecular:319.29N'-(2-Fluorophenyl)pyrazine-2-carbohydrazide
N'-(2-Fluorophenyl)pyrazine-2-carbohydrazide is a Ole1p desaturase inhibitor as well as antifungal agent [1].Fórmula:C11H9FN4OForma y color:SolidPeso molecular:232.21NA 382
CAS:NA 382 is a staurosporine derivative that inhibits multidrug resistance.Fórmula:C31H28N4O6Forma y color:SolidPeso molecular:552.58SphK1-IN-2
SphK1-IN-2: SphK1 inhibitor, IC50: 19.81 nM; less effective on SphK2. Induces apoptosis, hinders cancer cell growth.Fórmula:C27H30BrNO4SForma y color:SolidPeso molecular:544.5CXCR2 antagonist 7
CXCR2 antagonist 7 is a powerful blocker with IC50s: 0.044 μM for binding, 0.66 μM for calcium mobilization.Fórmula:C14H14F2N6OSForma y color:SolidPeso molecular:352.36PDE4B-IN-3
PDE4B-IN-3 is a potent inhibitor of PDE4B (IC50: 0.94 μM) and exhibits anti-inflammatory effects.Fórmula:C30H35N3O4S2Forma y color:SolidPeso molecular:565.75LY 541850
CAS:LY541850 is a selective orthosteric mGlu2 agonist and mGlu3 antagonist with IC50 values of 0.161 μM and 0.038 μM, respectively.LY 541850 is claimed from humanFórmula:C9H13NO4Pureza:98%Forma y color:SolidPeso molecular:199.2GNE-431
CAS:GNE-431: potent, selective noncovalent Btk inhibitor, IC50=3.2 nM; effective against C481R, T474I, T474M mutants, may counter ibrutinib resistance.Fórmula:C30H32N10O2Forma y color:SolidPeso molecular:564.64AMPK Activator SC4
CAS:SC4 is a potent, direct AMPK activator. SC4 preferentially activates α2 complexes and stimulates skeletal muscle glucose uptake.Fórmula:C26H18ClN3O4Forma y color:SolidPeso molecular:471.89RS 12254
CAS:RS 12254 is a dopamine agonist and antihypertensive agent.Fórmula:C28H40N2O4Pureza:98%Forma y color:SolidPeso molecular:468.63Deleobuvir
CAS:Deleobuvir(BI207127) is an inhibitor of non-nucleoside hepatitis C virus NS5B polymerase for the treatment of hepatitis C.Fórmula:C34H33BrN6O3Forma y color:SolidPeso molecular:653.57LY 292728
CAS:LY 292728 is a highly potent antagonist of leukotriene B4 receptor.Fórmula:C34H29FO9Pureza:98%Forma y color:SolidPeso molecular:600.59SB 243213 dihydrochloride
CAS:SB 243213 dihydrochloride is an orally active, selective and high-affinity antagonist of 5-hydroxytryptamine (5-HT)2C receptor(pKi of 9.37 and a pKb of 9.8 forFórmula:C22H21Cl2F3N4O2Pureza:98%Forma y color:SolidPeso molecular:501.33Aβ-IN-2
Aβ-IN-2 is a peptide inhibitor of Aβ1-42.Fórmula:C37H51NOForma y color:SolidPeso molecular:525.81Rostratin A
CAS:Rostratin A, a disulfide from Exserohilum rostratum, is cytotoxic to HCT-116 cells with an IC50 of 8.5 μg/mL.Fórmula:C18H24N2O6S2Forma y color:SolidPeso molecular:428.52DYRKs-IN-1 hydrochloride
CAS:DYRKs-IN-1 HCl inhibits DYRK1A (5 nM IC50) & DYRK1B (8 nM IC50) with antitumor properties.Fórmula:C30H31Cl2N7O4Forma y color:SolidPeso molecular:624.52LPM4870108
LPM4870108: Potent, oral pan-Trk inhibitor, selective over ALK, with anti-tumor effects. TrkC IC50=0.2nM, TrkA IC50=2.4nM.Fórmula:C20H19FN6O3Forma y color:SolidPeso molecular:410.4HDAC-IN-34
HDAC-IN-34 inhibits HDAC1 (IC50: 0.022 μM) & HDAC6 (IC50: 0.45 μM), binds DNA causing damage, and halts HCT-116 cell growth (IC50: 1.41 μM).Fórmula:C24H26N6O3Forma y color:SolidPeso molecular:446.5CBP/p300-IN-18
CBP/p300-IN-18 (compound 8) is a potent inhibitor of EP300/CBP HAT, acting on HAT EP300 (IC50: 0.056 μM) and LK2 H3K27 (IC50: 0.46 μM).Fórmula:C25H27FN4O3Forma y color:SolidPeso molecular:450.51Antileishmanial agent-6
Antileishmanial agent-6: potent against Leishmania donovani, IC50 0.54μM; cytotoxic IC50 10.2μM.Fórmula:C24H26O8Forma y color:SolidPeso molecular:442.46Tezampanel hydrate
CAS:Tezampanel is used for the treatment of migraine, neuropathic pain.Fórmula:C13H23N5O3Forma y color:SolidPeso molecular:297.35CY208-243 Mandelate
CAS:CY208-243 is a D1 agonist boosting memory in T-maze, enhances adenylate cyclase (EC50=125nM), and alters monkey electroretinogram.Fórmula:C27H26N2O3Forma y color:SolidPeso molecular:426.52JAK3/BTK-IN-4
CAS:JAK3/BTK-IN-4, a dual inhibitor for JAK3/BTK, shows synergy in autoimmune disease treatment. (Patent WO2021147953A1, compound 003)Fórmula:C21H25ClN8OForma y color:SolidPeso molecular:440.93CK156
CAS:CK156 inhibits DAPK with high selectivity; IC50: 182 nM (DRAK1), 34 μM (CK2a1), 39 μM (CK2a2); key in autoimmune/inflammation research.Fórmula:C21H25N5O3Forma y color:SolidPeso molecular:395.45Nnc 09-0026
CAS:Nnc 09-0026 is a neuronal calcium channel blockerFórmula:C25H35Cl2F3N2OForma y color:SolidPeso molecular:507.46Retezorogant
CAS:Retezorogant is a retinoic acid receptor-related orphan receptor gamma (RORγ) antagonist.Fórmula:C23H33ClN2O3Forma y color:SolidPeso molecular:420.97GYKI-53784
CAS:GYKI-53784 (LY 303070) is an effective selective AMPA receptor antagonist.Fórmula:C19H20N4O3Forma y color:SolidPeso molecular:352.39Zanapezil fumarate
CAS:Zanapezil is an acetylcholinesterase (AChE) inhibitor. Zanapezil increases choline acetyltransferase activity in cultured rat septal cholinergic neurons.Fórmula:C29H36N2O5Forma y color:SolidPeso molecular:492.61LEO 134310
CAS:LEO 134310: Selective, non-steroidal GR agonist with 14 nM EC50, for topical skin disease treatment.Fórmula:C34H40N2O8Forma y color:SolidPeso molecular:604.69SARS-CoV-2 nsp3-IN-1
Compound 15c selectively inhibits SARS-CoV-2 nsp3 Mac1 with IC50 of 6.1 μM.Fórmula:C17H15N5O2Forma y color:SolidPeso molecular:321.334-Bromo A23187
CAS:4-Bromo A23187 is a halogenated analog of the calcium ionophore A-23187. 4-Bromo A23187 is a calcium modulator and induces apoptosis in different cells.Fórmula:C29H36BrN3O6Pureza:98%Forma y color:SolidPeso molecular:602.52STING agonist-20
CAS:STING agonist-20: potent, aids in XMT-2056 synthesis, used as a cancer vaccine adjuvant.Fórmula:C36H39N11O8Forma y color:SolidPeso molecular:753.76ETX0282
CAS:ETX0282, oral class A/C β-lactamase inhibitor, developed by Entasis with cefpodoxime for bacterial infections.Fórmula:C13H18FN3O5Forma y color:SolidPeso molecular:315.30GNE-2256
CAS:GNE-2256, also known as molecule 19, is an orally active compound that inhibits Interleukin 1 receptor-associated kinase 4 (IRAK4) with a K i of 1.4 nM and hasFórmula:C24H27FN6O4Forma y color:SolidPeso molecular:482.51Multi-kinase-IN-1
CAS:Multi-kinase-IN-1, a powerful kinase inhibitor, exhibits antitumor properties by inducing cell apoptosis.Fórmula:C35H36F2N6O6SForma y color:SolidPeso molecular:706.76hDHODH-IN-10
hDHODH-IN-10: selective oral inhibitor of hDHODH (IC50: 10.9 nM); blocks cancer cell growth, aids cancer research.Fórmula:C21H15ClF4N2O4Forma y color:SolidPeso molecular:470.8FY-56
FY-56: potent, selective LSD1/KDM1A inhibitor (IC50=42nM); differentiates MOLM-13/MV4-11 cells; promising for AML research.Fórmula:C23H19FN2O3Forma y color:SolidPeso molecular:390.41G092
G092 is a potent inhibitor of MsbA. MsbA is an ABC transporter protein. G092 has potential for antibacterial drug research.Fórmula:C23H20Cl2N2O3Forma y color:SolidPeso molecular:443.32Mibefradil
CAS:Mibefradil is a calcium channel blocker with moderate selectivity for T-type Ca2+ channels (IC50s: 2.7 μM and 18.6 μM for T-type and L-type currents).Fórmula:C29H38FN3O3Pureza:98%Forma y color:SolidPeso molecular:495.63SARS-CoV-2 nsp14-IN-1
SARS-CoV-2 nsp14-IN-1 inhibits Nsp14 Mtase with an IC50 of 0.061 μM, affecting multiple substrates.Fórmula:C20H20N6O5SForma y color:SolidPeso molecular:456.48Terguride
CAS:Terguride: treats hyperprolactinemia, blocks 5-HT2A/B, activates dopamine receptors, studied for PAH.Fórmula:C20H28N4OForma y color:SolidPeso molecular:340.46MAP3K14-IN-173
CAS:MAP3K14-IN-173 is a potent MAP3K14 kinase inhibitor.Fórmula:C29H31N7O2Forma y color:SolidPeso molecular:509.60DC-U4106
CAS:DC-U4106: USP8 inhibitor, Kd 4.7μM, IC50 1.2μM, degrades Erα, low-toxicity tumor suppressor for breast cancer research.Fórmula:C29H27N5O5Forma y color:SolidPeso molecular:525.56T-3764518
CAS:T-3764518 is a novel and potent inhibitor of stearoyl coenzyme A desaturase (SCD)(IC50 of 4.7 nM).Fórmula:C20H17F6N5O2Pureza:98%Forma y color:SolidPeso molecular:473.37RORγt modulator 5
CAS:RORγt modulator 5, a potent RORγt modulator, exhibits a dissociation constant (K_i) of <100 nM.Fórmula:C27H22F5N3O6SForma y color:SolidPeso molecular:611.54GSK-3β inhibitor 6
GSK-3β inhibitor 6 is a highly potent inhibitor of GSK-3β, with an IC50 value of 24.4 μM.Fórmula:C20H17BrN4Forma y color:SolidPeso molecular:393.28IRL 2500
CAS:IRL 2500 is an antagonist of Endothelin receptor with IC50s of 1.3 and 94 nM for Endothelin A receptor and Endothelin B receptor.Fórmula:C36H35N3O4Pureza:99.36%Forma y color:White Crystalline SolidPeso molecular:573.685(S),6(R)-DiHETE
CAS:5(S),6(R)-DiHETE is a dihydroxy fatty acid from LTA4 hydrolysis and weak LTD4 agonist with ED50 of 1.3 μM for guinea pig ileum contraction.Fórmula:C20H32O4Forma y color:SolidPeso molecular:336.47Dictyostatin
CAS:Dictyostatin: potent microtubule stabilizer & anticancer agent with antiproliferative effects; researched for tauopathies.Fórmula:C32H52O6Forma y color:SolidPeso molecular:532.75Antibacterial agent 110
Compound 4e, an antibacterial against P. aeruginosa, disrupts cell membranes (MIC: 1 μg/ml).Fórmula:C22H21N5O4SForma y color:SolidPeso molecular:451.5HOE-288
CAS:HOE-288 is a converting enzyme (CE) inhibitor.Fórmula:C27H38N2O5Forma y color:SolidPeso molecular:470.60cSPM
cSPM (Cyclic spermine) is an Aβ42 inhibitor. cSPM inhibits the aggregation of three different peptides, Aβ42, tryptophan and insulin, and reduces cytotoxicity.Fórmula:C27H57N7Forma y color:SolidPeso molecular:479.79Eprociclovir Na
CAS:Eprociclovir Na (A-5021) is 15x stronger than acyclovir at inhibiting herpesviruses, showing promise for EHV1 and herpetic keratitis treatment.Fórmula:C11H14N5NaO3Forma y color:SolidPeso molecular:287.25ChemR23-IN-3
ChemR23-IN-3 is a potent thiazole-based ChemR23 inhibitor with an IC 80 value of 12 nM.Fórmula:C31H33N5O5S2Forma y color:SolidPeso molecular:619.75Sekdel sequence
CAS:Sekdel sequence, as a signal, leads to retention of at least two proteins in the endoplasmic reticulum of animal cells.Fórmula:C29H49N7O14Forma y color:SolidPeso molecular:719.74RBM10-8
CAS:RBM10-8 irreversibly inhibits human sphingosine-1- phosphate lyase (hS1PL) while behaving also as an enzyme substrate.Fórmula:C17H36NO5PForma y color:SolidPeso molecular:365.45Alkannin
CAS:Alkannin: potent, tumor-specific PKM2 inhibitor; non-inhibitory to PKM1/PKL; potential anticancer agent.Fórmula:C16H16O5Forma y color:SolidPeso molecular:288.3KRAS G12C inhibitor 50
CAS:KRAS G12C inhibitor 50 is a KRAS G12C inhibitor (IC50: 46.7 nM).Fórmula:C31H34N8O2Forma y color:SolidPeso molecular:550.65LSD1/2-IN-4
LSD1/2-IN-4, a PCPA derivative, inhibits LSD1 (Ki 0.11 μM) & LSD2 (Ki 130 μM), potentially useful in T-cell leukemia research.Fórmula:C9H8BrF2NForma y color:SolidPeso molecular:248.07B026
CAS:B026: Oral p300/CBP HAT inhibitor, IC50: p300 1.8 nM, CBP 9.5 nM; targets AR+ prostate cancer cells.Fórmula:C27H23F4N5O4Forma y color:SolidPeso molecular:557.5Lapaquistat
CAS:Lapaquistat: active TAK-475 metabolite; reduces cholesterol synthesis and statin myotoxicity.Fórmula:C31H39ClN2O8Pureza:98%Forma y color:SolidPeso molecular:603.1JBJ-09-063
CAS:JBJ-09-063: EGFR inhibitor, IC50s 0.147-0.396 nM for various mutants; hinders EGFR/Akt/ERK1/2 phosphorylation; targets TKI-sensitive/resistant lung cancer.Fórmula:C31H29FN4O3SForma y color:SolidPeso molecular:556.65YEATS4 binder-1
YEATS4 binder-1(4e) is an effective and selective compound that targets the KAc recognition site within the YEATS structural domain, exhibiting a bindingFórmula:C23H34N4O3Forma y color:SolidPeso molecular:414.54Bilanafos
CAS:Bilanafos is an agent of Anti-Bacterial.Fórmula:C11H22N3O6PPureza:98%Forma y color:SolidPeso molecular:323.28Cbl-b-IN-2
CAS:Cbl-b-IN-2 is an oral E3 enzyme inhibitor for immune-modulated diseases and cancer research.Fórmula:C29H30F5N5O2Forma y color:SolidPeso molecular:575.57OP-2507
CAS:OP-2507, a prostacyclin agonist, is used potentially for the treatment of hepatic insufficiency and hypertension.Fórmula:C25H41NO4Pureza:98%Forma y color:SolidPeso molecular:419.6PRN694
CAS:PRN694 is a potent, irreversible ITK/RLK inhibitor with IC50s: 0.3/1.4 nM; offers lasting effector cell suppression.Fórmula:C28H35F2N5O2SPureza:98%Forma y color:SolidPeso molecular:543.67IAA65
CAS:IAA65 is a potent inhibitor of T-type calcium channels, exhibiting an IC50 value of 18.9 μM, and holds potential for use in epilepsy research [1].Fórmula:C16H13F6NO2Forma y color:SolidPeso molecular:365.27PI3K-IN-23
PI3K-IN-23 is a (E)-9-oxooctadec-10-en-12-ynoic acid analogue that promotes glucose uptake (EC50: 7.00 μM).Fórmula:C24H33NO4SForma y color:SolidPeso molecular:431.5911-Oxahomoaminopterin
CAS:11-Oxahomoaminopterin exhibits antifolate activity against two folate-requiring microorganisms and inhibited Lactobacillus casei DHFR.Fórmula:C20H21N7O6Pureza:98%Forma y color:SolidPeso molecular:455.42GC 14
CAS:GC 14 is a selective thyroid hormone receptor antagonist, with IC50 values of 200 nM and 35 nM for hTRα and hTRβ, respectively.Fórmula:C26H27NO6Pureza:98%Forma y color:SolidPeso molecular:449.5Mt KARI-IN-1
Mt KARI-IN-1 inhibits Mtb KARI with a 3.06 μM Ki, targeting tuberculosis.Fórmula:C14H11N5O4S2Forma y color:SolidPeso molecular:377.4Steroid sulfatase-IN-4
Steroid sulfatase-IN-4 irreversibly inhibits human STS with a 25 nM IC50, useful for endometriosis research.Fórmula:C19H17ClN2O5SForma y color:SolidPeso molecular:420.87CAII-IN-3
CAII-IN-3, a thiosemicarbazone, potently inhibits CA-II with an IC50 of 13.4 μM.Fórmula:C18H18F2N4SForma y color:SolidPeso molecular:360.42TBK1/IKKε-IN-1
CAS:TBK1/IKKε-IN-1 is a dual inhibitor of TBK1 and IKKε (IC50s of <100 nM).Fórmula:C28H26N4O5Pureza:98%Forma y color:SolidPeso molecular:498.53AChE-IN-10
AChE-IN-10 (24r) inhibits AChE (IC50=2.4 nM), reducing amyloid buildup, tau phosphorylation, and promotes neuron health.Fórmula:C23H27F2NO4SForma y color:SolidPeso molecular:451.53Luffolide
CAS:Luffolide, a Luffariella sponge metabolite, shares manoalide's anti-inflammatory traits and fully inhibits PLA2's cleavage of phosphatidylcholine.Fórmula:C27H40O6Forma y color:SolidPeso molecular:460.60CDK8-IN-11 hydrochloride
CDK8-IN-11 HCl: potent, selective CDK8 inhibitor (IC50: 46 nM), blocks WNT/β-catenin pathway, used in colon cancer research.Fórmula:C19H16ClF3N4O2Forma y color:SolidPeso molecular:424.8Ketomethylenebestatin
CAS:Ketomethylenebestatin, a weaker carba-analog of aminopeptidase inhibitor bestatin, is 10x less potent.Fórmula:C17H25NO4Pureza:98%Forma y color:SolidPeso molecular:307.38GPR81 agonist 2
CAS:GPR81 agonist 2 is a potent agonist targeting the GPR81 receptor, demonstrating EC50 values of 0.023 µM for hGPR81 and 0.123 µM for hGPR109A, respectively.Fórmula:C26H27ClN6O5S2Forma y color:SolidPeso molecular:603.11BRD7539
CAS:BRD7539B: PfDHODH inhibitor, IC50 0.033μM; selective vs HsDHODH, IC50 >50μM.Fórmula:C23H22FN3O2Pureza:98%Forma y color:SolidPeso molecular:391.44CLR01 sodium
CAS:CLR01 is a tweezer reducing α-synuclein in MSA, inhibits SOD1 in ALS, blocks Ebola/Zika, stabilizes proteins, and lessens mutant p53 toxicity.Fórmula:C42H30Na2O8P2Forma y color:SolidPeso molecular:770.6211KCL-440
CAS:RS 57639 is a bioactive chemical.Fórmula:C18H18N2O2Forma y color:SolidPeso molecular:294.35IRAK4-IN-19
IRAK4-IN-19, an IRAK4 inhibitor (IC50: 4.3 nM), hampers IL23 synthesis and arthritis progression.Fórmula:C25H26F2N8OForma y color:SolidPeso molecular:492.52XIAP/cIAP1 antagonist-1
<p>Potent oral XIAP/cIAP1 inhibitor with EC50s: XIAP 5.1 nM, cIAP1 0.32 nM; curbs tumor growth in vivo.</p>Forma y color:SolidArterolane
CAS:Arterolane is an antimalarial compound. For against P. falciparum Ro73 and W2, the IC50s are both 1.1 nM.Fórmula:C22H36N2O4Forma y color:SolidPeso molecular:392.53Atorvastatin 3-Deoxyhept-2E-Enoic Acid
CAS:Atorvastatin 3-Deoxyhept-2E-Enoic Acid, an impurity in Atorvastatin, lowers blood lipids as an HMG-CoA reductase inhibitor.Fórmula:C33H33FN2O4Pureza:98%Forma y color:SolidPeso molecular:540.62DSP-1053 benzenesulfonate
CAS:DSP-1053: Benzylpiperidine-based, potent SERT inhibitor (Ki=1.02nM), partial 5-HT1A receptor agonist (Ki=5.05nM), antidepressant.Fórmula:C32H38BrNO7SForma y color:SolidPeso molecular:660.62HDAC6-IN-12
HDAC6-IN-12 is a potent inhibitor of HDAC6 that binds in the DNA chain, causing DNA damage and exhibiting anticancer effects that can be used in cancer researchFórmula:C24H39F2N3O5Forma y color:SolidPeso molecular:487.58Clavicoronic acid
CAS:Clavicoronic acid, a β-lactamase inhibitor, boosts penicillin antibiotics against resistant bacteria.Fórmula:C15H18O4Forma y color:SolidPeso molecular:262.3VEGFR-IN-3
CAS:VEGFR-IN-3 inhibits cancer cell growth (OVCAR-4, MDA-MB-468) with IC50s: 0.29, 0.35μM. Used in cancer research.Fórmula:C27H28N2O6Forma y color:SolidPeso molecular:476.52ARG1-IN-1
CAS:ARG1-IN-1 is a human arginase 1 inhibitor with an IC 50 of 29 nM.Fórmula:C11H21BN2O4Forma y color:SolidPeso molecular:256.11HBV-IN-12
CAS:HBV-IN-12: strong HBsAg & HBV DNA inhibitor; EC50 0.001-0.05 μM & 0.001-0.02 μM respectively. (WO2021204252A1)Fórmula:C23H27NO8Forma y color:SolidPeso molecular:445.46LSD1-IN-17
LSD1-IN-17, a potent LSD1/CoREST/MAO inhibitor, IC50: 0.005/0.028/0.820 μM; hinders LNCaP prostate cancer cell growth, IC50: 17.2 μM.Fórmula:C20H18N2OSForma y color:SolidPeso molecular:334.43SPR7
SPR7 is a potent and selective rhodesain inhibitor (Ki: 0.51 nM). SPR7 exhibited antiparasitic effects against T. b. brucei (EC50: 1.65 μM).Fórmula:C30H32ClN3O3Forma y color:SolidPeso molecular:518.05(+)-Sparteine sulfate pentahydrate
(+)-sparteine (sulfate pentahydrate) is a ganglion blocker that competitively blocks nicotinic acetylcholine receptors in neurons.Fórmula:C15H38N2O9SForma y color:SolidPeso molecular:422.54Integrase-LEDGF/p75 allosteric inhibitor 1
CAS:Oral HIV-1 allosteric integrase inhibitor, blocks DNA integration, antiviral, potent against NL432 (EC50: 3.9 nM).Fórmula:C33H41NO6SForma y color:SolidPeso molecular:579.75DNA-PK-IN-8
CAS:DNA-PK-IN-8: Potent, selective oral DNA-PK inhibitor, IC50 = 0.8 nM, boosts anti-cancer effects with Doxorubicin.Fórmula:C19H22N8O2Forma y color:SolidPeso molecular:394.43Antifungal agent 13
CAS:Antifungal agent 13 demonstrates significant antifungal activity against Sclerotinia sclerotiorum, achieving an EC50 of 1.25 mg/L.Fórmula:C21H16ClF3N4OForma y color:SolidPeso molecular:432.83EGFR/HER2/DHFR-IN-1
Potent EGFR/HER2/DHFR inhibitor for MCF-7 breast cancer; IC50: 0.153/0.108/0.291 μM; arrests G1/S phase, triggers apoptosis.Fórmula:C14H11BrN4O2SForma y color:SolidPeso molecular:379.23CBP/p300-IN-2
CAS:CBP/EP300-IN-2 is an inhibitor of CBP/EP300 (IC50s: 1.07 nM and 5.96 nM for CBP/HTRF and Myc).Fórmula:C27H29F2N7O2Pureza:98%Forma y color:SolidPeso molecular:521.56HER2-IN-9
HER2-IN-9, an oral HER2 inhibitor (IC50: 0.03 μM), hinders growth and spread of HER2+ breast cancer.Fórmula:C19H14BrF3N2OForma y color:SolidPeso molecular:423.23MI-1481
CAS:MI-1481: potent MML1 inhibitor, IC50 3.6 nM; disrupts menin-MLL1, active in MLL leukemia.Fórmula:C29H30F3N7O2SPureza:98%Forma y color:SolidPeso molecular:597.65DC4SMe
CAS:DC4SMe, a prodrug for targeted tumor therapy and ADC synthesis, has IC50s: 1.9 nM (Ramos), 2.9 nM (Namalwa), 1.8 nM (HL60/s).Fórmula:C35H31ClN5O7PS2Pureza:98%Forma y color:SolidPeso molecular:764.21Colistin adjuvant-2
Colistin adjuvant-2 is a compound that acts as a potentiation agent for colistin, effectively enhancing its activity against Gram-negative bacteria [1].Fórmula:C14H7Cl2F3N2OForma y color:SolidPeso molecular:347.12L-I-OddU
CAS:L-I-OddU: Selective anti-EBV, halts virus DNA/protein synthesis. EC50: 0.03 µM, low toxicity (CC50: 1000 nM).Fórmula:C8H9IN2O5Forma y color:SolidPeso molecular:340.07QCA570
CAS:QCA570 is an effective BET degrader based on PROTAC (IC50: 10 nM for BRD4 BD1 Protein).Fórmula:C39H33N7O4SPureza:98%Forma y color:SolidPeso molecular:695.79DFBTA
DFBTA inhibits ANO1 with IC50 of 24 nM, effectively treating inflammatory pain orally.Fórmula:C18H10ClF2NO3SForma y color:SolidPeso molecular:393.79BChE-IN-5
BChE-IN-5: potent, selective BChE inhibitor (IC50: 2.8 nM), more effective on hBChE, potential in Alzheimer's research.Fórmula:C30H42N4OForma y color:SolidPeso molecular:474.68Squalestatin 2
CAS:Squalestatin 2 is an inhibitor of squalene synthase.Fórmula:C33H44O13Pureza:98%Forma y color:SolidPeso molecular:648.69Deldeprevir Na
CAS:Deldeprevir Na is an Antiviral Polyprotein cleavage inhibitor. HCV NS3/4A inhibitor.Fórmula:C45H55F2N6NaO8S2Forma y color:SolidPeso molecular:933.08MK-6913
CAS:MK-6913 is a potent and selective agonist of estrogen receptor β.Fórmula:C25H27N3O2Pureza:98%Forma y color:SolidPeso molecular:401.5GNTI dihydrochloride
CAS:κ opioid receptor antagonistFórmula:C27H30ClN5O3Pureza:98%Forma y color:SolidPeso molecular:508.01Sdz 210-096
CAS:Sdz 210-096: a 14 beta-benzyl morphinan, mu/kappa opiate receptor antagonist, stimulates LH secretion in rats.Fórmula:C27H31NO2Forma y color:SolidPeso molecular:401.54Londamocitinib
CAS:Londamocitinib (JAK1-IN-7) is a selective and potent JAK1 inhibitor with anti-inflammatory activity.Fórmula:C28H31F2N7O4SPureza:98.64% - 99.56%Forma y color:SolidPeso molecular:599.65Ref: TM-T11706
1mg180,00€5mg439,00€10mg597,00€25mg905,00€50mg1.169,00€100mg1.568,00€1mL*10mM (DMSO)567,00€HDAC1-IN-5
HDAC1-IN-5 inhibits HDAC1 (IC50=15 nM) & HDAC6 (IC50=20 nM), promotes apoptosis, damages chromatin, and reduces tumor growth in mice.Fórmula:C20H21N3O2SForma y color:SolidPeso molecular:367.46JTE 151A
CAS:JTE-151 is a novel RORγ inverse agonist.Fórmula:C26H30ClN3O5Forma y color:SolidPeso molecular:499.99PRMT5-IN-1 hydrochloride
PRMT5 IN-1 hydrochloride is a potent PRMT5 inhibitor (IC50: 11 nM), forms covalent adduct with C449, and converts to an aldehyde in vivo.Fórmula:C19H20Cl2N4O5Forma y color:SolidPeso molecular:455.29MB-07344 sodium
"MB-07344 sodium is a TR-β agonist with a 2.17 nM Ki, boosts Atorvastatin's cholesterol-lowering effects in various animals."Fórmula:C19H25NaO5PPureza:98%Forma y color:SolidPeso molecular:387.36PARL-IN-1
PARL-IN-1: Strong PARL blocker, IC50 28 nM, boosts PINK1/Parkin mitophagy.Fórmula:C40H58N6O7Forma y color:SolidPeso molecular:734.92HS-731
CAS:HS-731 is a μ-Opioid Receptor Agonist.Fórmula:C20H26N2O5Forma y color:SolidPeso molecular:374.43M-COPA
CAS:M-COPA disrupts Golgi, blocks MET & Arf1 activation, and inhibits angiogenesis via VEGFR & NF-kB pathways.Fórmula:C25H34N2O2Forma y color:SolidPeso molecular:394.55BU09059
CAS:BU09059 is a potent, selective, short-acting antagonist of the κ-opioid receptor (KOR).Fórmula:C28H37N3O5Pureza:98%Forma y color:SolidPeso molecular:495.61BMS-520
CAS:BMS-520: potent oral S1P1 agonist, effective in rat arthritis and mouse multiple sclerosis model.Fórmula:C23H17F3N4O4Forma y color:SolidPeso molecular:470.4Uprosertib hydrochloride
CAS:Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180/328/38 nM for Akt1/Akt2/Akt3, respectively).Fórmula:C18H17Cl3F2N4O2Pureza:98%Forma y color:SolidPeso molecular:465.71GLS1 Inhibitor-5
GLS1 Inhibitor-5 (24y): Selective, oral glutaminase 1 inhibitor; IC50 68 nM; induces apoptosis; anti-tumor.Forma y color:SolidAnticancer agent 68
CAS:Compound 12, an anticancer agent, halts G2/M phase, triggers cell death, and activates p53 & PTEN for tumor suppression.Fórmula:C20H18ClNO5Forma y color:SolidPeso molecular:387.81Tubulin inhibitor 14
Tubulin inhibitor 14 blocks NQO2 and microtubule formation, disrupts blood vessels, and may target tumors; IC50 of 1.0 μM.Fórmula:C15H9F2NOForma y color:SolidPeso molecular:257.23Esorubicin
CAS:Esorubicin, a doxorubicin derivative, intercalates DNA, inhibits topoisomerase II, has less cardiotoxicity, but more myelosuppression.Fórmula:C27H29NO10Forma y color:SolidPeso molecular:527.52Danshenxinkun D
CAS:Danshenxinkun D has antituberculosis H_(37)Rv activity in vitro.Fórmula:C21H20O4Pureza:98%Forma y color:SolidPeso molecular:336.38HIV-1 inhibitor-44
HIV-1 inhibitor-44 (compound 11l) is an HIV-1 reverse transcriptase inhibitor that exhibits activity against wild-type HIV-1 strains (EC50: 0.209 μM).Fórmula:C23H26N2O4SForma y color:SolidPeso molecular:426.53GABAA receptor agonist 1
Compound 3e, a potent GABAA agonist, targets GABA sites and has potential anti-depressive effects in mice.Fórmula:C20H30O3Forma y color:SolidPeso molecular:318.45UK 356618
CAS:<p>UK 356618 is a potent and selective inhibitor of matrix metalloprotease-3 (IC50: 5.9 nM).</p>Fórmula:C34H43N3O4Pureza:98%Forma y color:SolidPeso molecular:557.72Antibacterial agent 82
Antibacterial agent 82 (compound 7p) is an antibacterial agent [1].Fórmula:C22H18N2O2Forma y color:SolidPeso molecular:342.39(25S)-δ7-Dafachronic acid
CAS:(25S)-delta7-Dafachronic acid, an orphan nuclear receptor DAF-12 ligand, inhibits the dauer-promoting activity of DAF-12.Fórmula:C27H42O3Pureza:98%Forma y color:SolidPeso molecular:414.62HMG499
CAS:HMG499 inhibits HMG-CoA reductase (IC50: 0.41μM), reduces statin-induced HMGCR, lowers cholesterol, and lessens atherosclerosis.Fórmula:C33H54O3Pureza:98%Forma y color:SolidPeso molecular:498.78Antimalarial agent 2
Antimalarial agent 2 is an orally active, novel antimalarial agent that exhibits rapid in vitro killing effects.Fórmula:C27H25N3O5Forma y color:SolidPeso molecular:471.5CXCR4 probe 1
CAS:CXCR4 probe 1, a specific PET tracer, targets CXCR4 with antagonist TN14003 (IC50: 6.9 nM), aiding in imaging CXCR4-related diseases and tumors.Fórmula:C24H30FN5O4SForma y color:SolidPeso molecular:502.59S100A2-p53-IN-1
CAS:S100A2-p53-IN-1 inhibits S100A2-p53 in pancreatic cancer, stunting MiaPaCa-2 cell growth at 1.2-3.4 μM.Fórmula:C20H20F6N2O4SForma y color:SolidPeso molecular:498.44Antimalarial agent 7
Antimalarial agent 7 is a potent and effective inhibitor of PfATP4. Antimalarial agent 7 has potential for the study of the human plasmodium falciparum.Fórmula:C23H22F2N4O3Forma y color:SolidPeso molecular:440.44HBV-IN-11
CAS:HBV-IN-11 is a potent inhibitor of HBsAg secretion (EC50: 0.46 μM).Fórmula:C21H24ClNO6Forma y color:SolidPeso molecular:421.87hCA VB-IN-1
hCA VB-IN-1 (compound 15) is a potent and selective inhibitor of hCA VB (carbonic anhydrase) with a KI of 515.7 nM [1].Fórmula:C9H13N3O4SForma y color:SolidPeso molecular:259.28GL0388
GL0388, a Bax activator, induces apoptosis, hinders breast cancer growth, and has IC50 of 0.299-1.57 μM.Fórmula:C21H17FN2OForma y color:SolidPeso molecular:332.37MRS4738
MRS4738 is a potent antagonist with high affinity for the P2Y14R receptor. It demonstrates in vivo anti-hyperallodynic and antiasthmatic activity [1].Fórmula:C30H24F3NO2Forma y color:SolidPeso molecular:487.51Homomoschatoline
CAS:Homomoschatoline is an antibacterial isolated from Artabotrys crassifolius.Fórmula:C19H15NO4Pureza:98%Forma y color:SolidPeso molecular:321.33EGFR-IN-3
EGFR-IN-3 is an EGFR inhibitor with antitumor activity.EGFR-IN-3 inhibits EGFRwt-TK, induces apoptosis (cell death), and can block cells in the G2/M phase.Fórmula:C24H18F4N6O2SPureza:98.1%Forma y color:SolidPeso molecular:530.5BRD-K98645985
CAS:BRD-K98645985: BAF inhibitor, binds ARID1A, reverses HIV-1 latency, EC50 ~2.37μM, alters nucleosome placement.Fórmula:C33H43N5O4Pureza:98%Forma y color:SolidPeso molecular:573.73Methyl 5-thia-6,8,11,14-eicosatetraenoate
CAS:Methyl 5-thia-6,8,11,14-eicosatetraenoate is a bioactive chemical.Fórmula:C20H32O2SForma y color:SolidPeso molecular:336.53LSD1/2-IN-3
LSD1/2-IN-3 selectively inhibits LSD1 (Ki 11 nM) over LSD2 (Ki 7 μM), and hinders tumor stem cell proliferation.Fórmula:C9H8BrF2NForma y color:SolidPeso molecular:248.07PD 136450
CAS:PD-136,450: partial stomach secretory agonist, full pancreas agonist in rats; potential acid-reducing drug, adjuvant for gastrin-sensitive tumors.Fórmula:C35H40N4O6Pureza:98%Forma y color:SolidPeso molecular:612.72MtTMPK-IN-5
MtTMPK-IN-5 inhibits Mtb TMPK with IC50 of 34 μM and fights tuberculosis with MIC of 12.5 μM, aiding TB research.Fórmula:C21H23N5O2Forma y color:SolidPeso molecular:377.44Mu opioid receptor antagonist 3
Potent, selective MOR antagonist (compound 26); crosses blood-brain barrier. Ki: 0.24 nM, EC50: 0.54 nM; for studying OUD.Fórmula:C25H28N2O4SForma y color:SolidPeso molecular:452.57TAK-828F
CAS:TAK-828F: potent, selective RORγt inverse agonist. Oral. IC50=1.9 nM; reporter gene IC50=6.1 nM.Fórmula:C28H32FN3O5Pureza:98%Forma y color:SolidPeso molecular:509.578-Deazafolic acid
CAS:8-Deazafolic acid inhibits folate-dependent bacteria S. faecium & L. casei, and fights lymphoid leukemia L1210 in mice.Fórmula:C20H20N6O6Pureza:98%Forma y color:SolidPeso molecular:440.41Macropa-NCS
CAS:Macropa-NCS is a macropa bifunctional analog with antitumor activity and can be used to study prostate cancer.Fórmula:C27H35N5O8SPureza:98%Forma y color:SolidPeso molecular:589.66FNDR-20123
FNDR-20123: First safe, effective anti-malarial HDAC inhibitor for Plasmodium (IC50: 31 nM) & human HDACs, with nanomolar potency across several subtypes.Fórmula:C21H24ClN5O2Forma y color:SolidPeso molecular:413.9Nenocorilant
CAS:Nenocorilant (Relacorilant) is an orally active glucocorticoid receptor (GR) antagonist (Ki: 0.15 nM). Nenocorilant can be used to study tumours.Fórmula:C26H21F4N7O3SForma y color:SolidPeso molecular:587.55URAT1 inhibitor 3
URAT1 inhibitor 3: potent oral URAT1 blocker, IC50=0.8 nM, for gout/hyperuricemia study.Fórmula:C14H8Cl2N2O2Forma y color:SolidPeso molecular:307.13BI 224436
CAS:BI 224436 is an inhibitor of HIV-1 noncatalytic site integrase. With EC50 values of less than 15 nM against different HIV-1 laboratory strains.Fórmula:C27H26N2O4Forma y color:SolidPeso molecular:442.51KIRA9
KIRA9 inhibits IRE1 with a 4.8 μM IC50, blocking ER-stress-induced mRNA decay and apoptosis by fully binding IRE1's ATP site.Fórmula:C27H27F3N6O3SForma y color:SolidPeso molecular:572.6LLS30
CAS:LLS30 inhibits Gal-1, reduces its binding affinity, and may help treat advanced prostate cancer.Fórmula:C34H33Cl4N5O3Forma y color:SolidPeso molecular:701.47Keap1-Nrf2-IN-1 TFA
Keap1-Nrf2-IN-1 TFA (compound35) is a potent inhibitor (IC50: 43 nM) protecting against acetaminophen liver damage.Fórmula:C26H25F3N2O9SForma y color:SolidPeso molecular:598.54EGFR-IN-45
EGFR-IN-45: Strong EGFR/CDK2 inhibitor (IC50s: 0.4 & 1.6 μM), halts cancer cell cycle pre-G1, prompts apoptosis, also targets Topo I/II.Fórmula:C28H23N7OForma y color:SolidPeso molecular:473.53Pefcalcitol
CAS:Pefcalcitol is a novel antipsoriatic prodrug candidate containing a 16-en-22-oxa-vitamin D3 structure.Fórmula:C26H34F5NO4Forma y color:SolidPeso molecular:519.54ERK-IN-2
CAS:ERK-IN-2, an ERK2 inhibitor, exhibits an IC50 value of 1.8 nM. At doses greater than 10 μM, it may induce off-target toxicity and/or activity [1].Fórmula:C16H18ClN5O2Pureza:98%Forma y color:SolidPeso molecular:347.80Abarelix acetate
CAS:Abarelix acetate: synthetic GnRHR antagonist, spikes histamine, lowers LH and testosterone temporarily, used in advanced prostate cancer.Fórmula:C72H95ClN14O14·xC2H4O2Forma y color:SolidPeso molecular:1476.14Antitubercular agent-16
Compound 5q is a potent antitubercular with low MIC90 values (0.40-23.51 μg/mL) against M. tuberculosis strains, showing minimal cytotoxicity.Fórmula:C21H27N3SForma y color:SolidPeso molecular:353.52Antibacterial agent 75
Antibacterial agent 75 re-sensitizes VRSA to vancomycin.Fórmula:C22H28N6OForma y color:SolidPeso molecular:392.5Tarloxotinib bromide
CAS:Tarloxotinib bromide (TH-4000) is an irreversible inhibitor of EGFR/HER2.Fórmula:C24H24Br2ClN9O3Pureza:99.52%Forma y color:SolidPeso molecular:681.77Ref: TM-T13088
1mg140,00€5mg283,00€10mg432,00€25mg707,00€50mg938,00€100mg1.311,00€1mL*10mM (DMSO)437,00€L 365209
CAS:L 365209 is an oxytocin antagonist.Fórmula:C40H50N8O6Pureza:98%Forma y color:SolidPeso molecular:738.88Antibacterial agent 78
Antibacterial agent 78 (compound 30) is an antibacterial agent with improved cytotoxicity profile[1].Fórmula:C16H23N3S2Forma y color:SolidPeso molecular:321.5AFP-07
CAS:AFP-07 is a highly selective and potent agonist. It was used for the prostacyclin receptor.Fórmula:C22H29F2NaO5Pureza:98%Forma y color:SolidPeso molecular:434.45Anti-ToCV agent 1
Anti-ToCV agent 1 can be used as a potential anti-ToCV drug.Fórmula:C22H19FN2O5SForma y color:SolidPeso molecular:442.46sEH inhibitor-4
Compound B15: potent sEH inhibitor (0.03 nm), reduces inflammation & pain.Fórmula:C27H28Cl2N4O3Forma y color:SolidPeso molecular:527.44PPARα agonist 1
PPARα agonist 1 is a complete and potent PPARα agonist.Fórmula:C27H34O4Forma y color:SolidPeso molecular:422.56MraY-IN-3
MraY-IN-3 (12a) is a potent inhibitor of the bacterial translocase MraY (IC50: 140 μM). 46 μg/ml).Fórmula:C35H45N3O5Forma y color:SolidPeso molecular:587.75KFA1982
CAS:KFA1982 is a novel and potent factor Xa inhibitor.Fórmula:C28H34ClN3O9S2Forma y color:SolidPeso molecular:656.17LSD1-IN-22
LSD1-IN-22: potent LSD1 inhibitor, K_i 98 nM, curbs cancer cell growth.Fórmula:C9H8BrF2NForma y color:SolidPeso molecular:248.07AFP-07 free acid
CAS:AFP 07 free acid is a 7,7-difluoroprostacyclin derivative. It also acts as a selective and highly potent agonist for the IP receptor.Fórmula:C22H30F2O5Pureza:98%Forma y color:SolidPeso molecular:412.47Anti-MRSA agent 3
CAS:Anti-MRSA agent 3 targets MRSA with 0.098 μg/ml MIC, low toxicity, binds DNA, and disrupts cell walls/membranes.Fórmula:C29H18BrN3O2Forma y color:SolidPeso molecular:520.386Dopamine D3 receptor antagonist-1
Dopamine D3 receptor antagonist-1 is a dopamine D3 receptor selective or multi-targeting ligand with a Ki value of 1.58 nM that has demonstrated therapeuticFórmula:C31H35Cl2N3O3Forma y color:SolidPeso molecular:568.53Ophiobolin C
CAS:inhibitor of human CCR5 binding to HIV-1 gp120Fórmula:C25H38O3Pureza:98%Forma y color:SolidPeso molecular:386.57NTU281
CAS:NTU281 inhibits transglutaminase-2, lowers creatinine in diabetic rats, reduces proteinuria, and fights glomerulosclerosis.Fórmula:C25H31N2O6SForma y color:SolidPeso molecular:487.59iNOs-IN-1
iNOs-IN-1 (YPW) is a strong iNOS inhibitor with dose-dependent anti-inflammatory properties, reducing IL-6, iNOS, and NO levels.Fórmula:C25H30N4O5Forma y color:SolidPeso molecular:466.53ABD957
CAS:ABD957: covalent ABHD17 depalmitoylases inhibitor, IC50 0.21µM for ABHD17B, blocks N-Ras, halts NRAS-mutant AML cell growth.Fórmula:C27H36F3N7O5SForma y color:SolidPeso molecular:627.68
